Clinical trials recruiting in North Richland Hills, Texas
3
Recruiting trials
6
Conditions
Phase breakdown
Phase 3 2Not applicable 1
Conditions recruiting in North Richland Hills, Texas
| Condition | Trials |
|---|---|
| Obesity | 2 |
| Atherosclerotic Cardiovascular Disease | 1 |
| COPD | 1 |
| COPD (Chronic Obstructive Pulmonary Disease) | 1 |
| Obesity or Overweight | 1 |
| Overweight | 1 |
Recruiting trials in North Richland Hills, Texas
- Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
Common questions
How many clinical trials are recruiting in North Richland Hills, Texas?
3 recruiting trials have at least one study site in North Richland Hills, Texas.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.